Symbols / BIIB $190.13 +2.25% Biogen Inc.
BIIB Chart
About
No company description available for this symbol.
Fundamentals
Scroll to Statements| Market Cap | 27.89B | Enterprise Value | — | Income | — | Sales | — | Book/sh | — | Cash/sh | — |
| Dividend Yield | — | Payout | — | Employees | — | IPO | — | P/E | 21.60 | Forward P/E | — |
| PEG | — | P/S | — | P/B | — | P/C | — | EV/EBITDA | — | EV/Sales | — |
| Quick Ratio | — | Current Ratio | — | Debt/Eq | — | LT Debt/Eq | — | EPS (ttm) | — | EPS next Y | — |
| EPS Growth | — | Revenue Growth | — | Earnings | — | ROA | — | ROE | — | ROIC | — |
| Gross Margin | — | Oper. Margin | — | Profit Margin | — | Shs Outstand | — | Shs Float | — | Short Float | — |
| Short Ratio | — | Short Interest | — | 52W High | — | 52W Low | — | Beta | — | Avg Volume | — |
| Volume | — | Target Price | — | Recom | — | Prev Close | $185.95 | Price | $190.13 | Change | 2.25% |
Valuation Models
Price estimates from analyst targets and simple models.
Ratings
- BIIB Stock Price Prediction 2025-2026 | Biogen Inc Forecast | 24/7 Wall St. - 24/7 Wall St. Wed, 22 Apr 2026 19
- Biogen (BIIB) Stock Trades Up, Here Is Why - Yahoo Finance Mon, 20 Apr 2026 23
- BIIB (Biogen) Short Ratio - GuruFocus Wed, 22 Apr 2026 16
- Biogen pays $100M to take full global control of felzartamab - Stock Titan Mon, 20 Apr 2026 11
- UBS upgrades Biogen stock rating on pipeline catalysts, raises target to $225 - Investing.com Wed, 22 Apr 2026 07
- BIIB Inks Deal to Acquire Rights to Felzartamab in China, Stock Up - Zacks Investment Research ue, 21 Apr 2026 15
- UBS Upgrades Biogen to Buy With a $225 Target: Are the Next 12 Months a Pipeline Catalyst Parade? - 24/7 Wall St. Wed, 22 Apr 2026 14
- 3 Reasons to Avoid BIIB and 1 Stock to Buy Instead - Yahoo Finance ue, 21 Apr 2026 15
- BIIB Upgraded by UBS -- Price Target Raised to $225 - GuruFocus Wed, 22 Apr 2026 15
- BIIB (Biogen) Other Income (Minority Interest) : $0 Mil (TTM As of Dec. 2025) - GuruFocus Wed, 22 Apr 2026 17
- Wells Fargo Upgrades Biogen to Overweight: Does the Alzheimer's Story Finally Have a Second Act? - 24/7 Wall St. Mon, 20 Apr 2026 15
- Earnings Preview: Biogen Inc. (BIIB) Q1 Earnings Expected to Decline - Yahoo Finance Wed, 22 Apr 2026 14
- Should Value Investors Buy Biogen (BIIB) Stock? - Yahoo Finance Fri, 17 Apr 2026 13
- BIIB (Biogen) Purchase Of Business : $0 Mil (TTM As of Dec. 2025) - GuruFocus Wed, 22 Apr 2026 16
- BIIB (Biogen) Change In Prepaid Assets : $0 Mil (TTM As of Dec. 2025) - GuruFocus Wed, 22 Apr 2026 16
Insider Transactions
No recent insider transactions.
Financials
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
9,890.60
+2.22%
|
9,675.90
-1.62%
|
9,835.60
-3.32%
|
10,173.40
|
| Operating Revenue |
|
9,890.60
+2.22%
|
9,675.90
-1.62%
|
9,835.60
+1.52%
|
9,688.30
|
| Cost Of Revenue |
|
2,404.20
+4.06%
|
2,310.40
-8.80%
|
2,533.40
+11.20%
|
2,278.30
|
| Reconciled Cost Of Revenue |
|
2,139.30
+2.66%
|
2,083.90
-8.57%
|
2,279.20
+7.22%
|
2,125.80
|
| Gross Profit |
|
7,486.40
+1.64%
|
7,365.50
+0.87%
|
7,302.20
-7.51%
|
7,895.10
|
| Operating Expense |
|
5,017.40
-1.33%
|
5,085.10
-6.77%
|
5,454.50
+9.24%
|
4,993.20
|
| Research And Development |
|
1,778.60
-10.19%
|
1,980.30
-19.02%
|
2,445.40
+9.61%
|
2,231.10
|
| Selling General And Administration |
|
2,433.60
+1.24%
|
2,403.70
-5.73%
|
2,549.70
+6.08%
|
2,403.60
|
| Other Operating Expenses |
|
290.20
+14.07%
|
254.40
+16.27%
|
218.80
+3056.76%
|
-7.40
|
| Total Expenses |
|
7,421.60
+0.35%
|
7,395.50
-7.42%
|
7,987.90
+9.85%
|
7,271.50
|
| Operating Income |
|
2,469.00
+8.27%
|
2,280.40
+23.42%
|
1,847.70
-36.33%
|
2,901.90
|
| Total Operating Income As Reported |
|
—
|
—
|
—
|
—
|
| EBITDA |
|
2,603.90
-7.97%
|
2,829.50
+38.80%
|
2,038.50
-53.21%
|
4,356.80
|
| Normalized EBITDA |
|
3,398.60
+9.40%
|
3,106.50
+18.60%
|
2,619.40
-25.15%
|
3,499.50
|
| Reconciled Depreciation |
|
779.90
+15.85%
|
673.20
+36.05%
|
494.80
-4.55%
|
518.40
|
| EBIT |
|
1,824.00
-15.41%
|
2,156.30
+39.68%
|
1,543.70
-59.78%
|
3,838.40
|
| Total Unusual Items |
|
-794.70
-186.90%
|
-277.00
+52.32%
|
-580.90
-167.76%
|
857.30
|
| Total Unusual Items Excluding Goodwill |
|
-794.70
-186.90%
|
-277.00
+52.32%
|
-580.90
-167.76%
|
857.30
|
| Special Income Charges |
|
-746.40
-412.29%
|
-145.70
+39.11%
|
-239.30
-120.45%
|
1,170.10
|
| Other Special Charges |
|
611.30
+596.24%
|
87.80
+328.29%
|
20.50
-97.76%
|
917.00
|
| Impairment Of Capital Assets |
|
52.90
|
0.00
|
0.00
|
—
|
| Restructuring And Mergern Acquisition |
|
82.20
+41.97%
|
57.90
-73.54%
|
218.80
+380.51%
|
-78.00
|
| Net Income |
|
1,292.90
-20.79%
|
1,632.20
+40.57%
|
1,161.10
-61.89%
|
3,046.90
|
| Pretax Income |
|
1,556.50
-18.34%
|
1,906.00
+46.98%
|
1,296.80
-63.90%
|
3,591.80
|
| Net Non Operating Interest Income Expense |
|
-142.50
+22.00%
|
-182.70
-717.23%
|
29.60
+118.82%
|
-157.30
|
| Interest Expense Non Operating |
|
267.50
+6.87%
|
250.30
+1.38%
|
246.90
+0.12%
|
246.60
|
| Net Interest Income |
|
-142.50
+22.00%
|
-182.70
-717.23%
|
29.60
+118.82%
|
-157.30
|
| Interest Expense |
|
267.50
+6.87%
|
250.30
+1.38%
|
246.90
+0.12%
|
246.60
|
| Interest Income Non Operating |
|
125.00
+84.91%
|
67.60
-75.55%
|
276.50
+209.63%
|
89.30
|
| Interest Income |
|
125.00
+84.91%
|
67.60
-75.55%
|
276.50
+209.63%
|
89.30
|
| Other Income Expense |
|
-770.00
-301.67%
|
-191.70
+66.98%
|
-580.50
-168.52%
|
847.20
|
| Other Non Operating Income Expenses |
|
24.70
-71.04%
|
85.30
+21225.00%
|
0.40
+103.96%
|
-10.10
|
| Gain On Sale Of Security |
|
-48.30
+63.21%
|
-131.30
+61.56%
|
-341.60
-9.21%
|
-312.80
|
| Gain On Sale Of Business |
|
—
|
0.00
|
0.00
-100.00%
|
1,505.40
|
| Tax Provision |
|
263.60
-3.73%
|
273.80
+102.37%
|
135.30
-78.62%
|
632.80
|
| Tax Rate For Calcs |
|
0.00
+17.89%
|
0.00
+38.13%
|
0.00
-40.91%
|
0.00
|
| Tax Effect Of Unusual Items |
|
-134.59
-238.23%
|
-39.79
+34.13%
|
-60.41
-140.04%
|
150.88
|
| Net Income Including Noncontrolling Interests |
|
1,292.90
-20.79%
|
1,632.20
+40.53%
|
1,161.50
-60.78%
|
2,961.60
|
| Net Income From Continuing Operation Net Minority Interest |
|
1,292.90
-20.79%
|
1,632.20
+40.57%
|
1,161.10
-61.89%
|
3,046.90
|
| Net Income From Continuing And Discontinued Operation |
|
1,292.90
-20.79%
|
1,632.20
+40.57%
|
1,161.10
-61.89%
|
3,046.90
|
| Net Income Continuous Operations |
|
1,292.90
-20.79%
|
1,632.20
+40.53%
|
1,161.50
-60.78%
|
2,961.60
|
| Minority Interests |
|
0.00
|
0.00
+100.00%
|
-0.40
-100.47%
|
85.30
|
| Normalized Income |
|
1,953.01
+4.47%
|
1,869.41
+11.17%
|
1,681.59
-28.15%
|
2,340.48
|
| Net Income Common Stockholders |
|
1,292.90
-20.79%
|
1,632.20
+40.57%
|
1,161.10
-61.89%
|
3,046.90
|
| Diluted EPS |
|
8.79
-21.38%
|
11.18
+40.28%
|
7.97
-61.81%
|
20.87
|
| Basic EPS |
|
8.83
-21.23%
|
11.21
+39.78%
|
8.02
-61.74%
|
20.96
|
| Basic Average Shares |
|
146.50
+0.62%
|
145.60
+0.62%
|
144.70
-0.41%
|
145.30
|
| Diluted Average Shares |
|
147.10
+0.82%
|
145.90
+0.21%
|
145.60
-0.27%
|
146.00
|
| Diluted NI Availto Com Stockholders |
|
1,292.90
-20.79%
|
1,632.20
+40.57%
|
1,161.10
-61.89%
|
3,046.90
|
| Amortization |
|
515.00
+15.29%
|
446.70
+85.66%
|
240.60
-34.24%
|
365.90
|
| Amortization Of Intangibles Income Statement |
|
515.00
+15.29%
|
446.70
+85.66%
|
240.60
-34.24%
|
365.90
|
| Depreciation Amortization Depletion Income Statement |
|
515.00
+15.29%
|
446.70
+85.66%
|
240.60
-34.24%
|
365.90
|
| Depreciation And Amortization In Income Statement |
|
515.00
+15.29%
|
446.70
+85.66%
|
240.60
-34.24%
|
365.90
|
| Earnings From Equity Interest Net Of Tax |
|
—
|
0.00
|
0.00
-100.00%
|
2.60
|
| Gain On Sale Of PPE |
|
—
|
0.00
|
0.00
-100.00%
|
503.70
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Assets |
|
29,439.50
+4.96%
|
28,049.30
+4.49%
|
26,844.80
+9.33%
|
24,554.10
|
| Current Assets |
|
8,974.10
+20.35%
|
7,456.80
+8.71%
|
6,859.30
-29.94%
|
9,791.20
|
| Cash Cash Equivalents And Short Term Investments |
|
3,815.70
+60.66%
|
2,375.00
+126.21%
|
1,049.90
-78.54%
|
4,892.80
|
| Cash And Cash Equivalents |
|
3,008.50
+26.67%
|
2,375.00
+126.21%
|
1,049.90
-69.29%
|
3,419.30
|
| Other Short Term Investments |
|
807.20
|
0.00
|
0.00
-100.00%
|
1,473.50
|
| Receivables |
|
1,867.00
-0.10%
|
1,868.80
-11.01%
|
2,100.00
-1.70%
|
2,136.40
|
| Accounts Receivable |
|
1,867.00
-0.10%
|
1,868.80
-11.01%
|
2,100.00
-1.70%
|
2,136.40
|
| Gross Accounts Receivable |
|
1,870.00
-0.05%
|
1,871.00
-11.01%
|
2,102.40
-1.70%
|
2,138.70
|
| Allowance For Doubtful Accounts Receivable |
|
-3.00
-36.36%
|
-2.20
+8.33%
|
-2.40
-4.35%
|
-2.30
|
| Inventory |
|
2,168.10
-11.88%
|
2,460.50
-2.65%
|
2,527.40
+87.99%
|
1,344.40
|
| Raw Materials |
|
—
|
—
|
—
|
413.20
|
| Work In Process |
|
—
|
—
|
—
|
751.90
|
| Finished Goods |
|
—
|
—
|
—
|
200.40
|
| Other Current Assets |
|
1,123.30
+49.28%
|
752.50
-36.34%
|
1,182.00
-16.62%
|
1,417.60
|
| Total Non Current Assets |
|
20,465.40
-0.62%
|
20,592.50
+3.04%
|
19,985.50
+35.38%
|
14,762.90
|
| Net PPE |
|
3,320.80
-6.13%
|
3,537.70
-5.15%
|
3,729.70
+0.73%
|
3,702.50
|
| Gross PPE |
|
6,252.00
+0.70%
|
6,208.50
+1.24%
|
6,132.20
+4.50%
|
5,868.20
|
| Accumulated Depreciation |
|
-2,931.20
-9.75%
|
-2,670.80
-11.17%
|
-2,402.50
-10.93%
|
-2,165.70
|
| Properties |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Land And Improvements |
|
216.70
+7.07%
|
202.40
+0.00%
|
202.40
+0.00%
|
202.40
|
| Buildings And Improvements |
|
2,140.30
+8.99%
|
1,963.70
+22.63%
|
1,601.30
+0.53%
|
1,592.90
|
| Machinery Furniture Equipment |
|
3,323.00
+2.57%
|
3,239.80
+15.81%
|
2,797.40
+4.67%
|
2,672.50
|
| Construction In Progress |
|
163.10
-47.11%
|
308.40
-68.38%
|
975.40
+9.74%
|
888.80
|
| Other Properties |
|
265.40
-25.53%
|
356.40
-15.14%
|
420.00
+3.99%
|
403.90
|
| Leases |
|
143.50
+4.14%
|
137.80
+1.55%
|
135.70
+26.00%
|
107.70
|
| Goodwill And Other Intangible Assets |
|
15,669.60
-3.10%
|
16,170.10
+10.89%
|
14,582.20
+91.89%
|
7,599.10
|
| Goodwill |
|
6,491.10
+0.19%
|
6,478.90
+4.18%
|
6,219.20
+8.18%
|
5,749.00
|
| Other Intangible Assets |
|
9,178.50
-5.29%
|
9,691.20
+15.88%
|
8,363.00
+352.03%
|
1,850.10
|
| Investments And Advances |
|
431.90
|
0.00
|
0.00
-100.00%
|
705.70
|
| Other Investments |
|
—
|
—
|
—
|
1,529.20
|
| Non Current Deferred Assets |
|
292.50
-9.78%
|
324.20
-65.09%
|
928.60
-24.28%
|
1,226.40
|
| Non Current Deferred Taxes Assets |
|
292.50
-9.78%
|
324.20
-65.09%
|
928.60
-24.28%
|
1,226.40
|
| Other Non Current Assets |
|
750.60
+33.92%
|
560.50
-24.77%
|
745.00
-51.28%
|
1,529.20
|
| Total Liabilities Net Minority Interest |
|
11,182.70
-1.33%
|
11,333.30
-5.91%
|
12,045.40
+7.88%
|
11,165.70
|
| Current Liabilities |
|
3,349.40
-39.42%
|
5,528.80
+60.99%
|
3,434.30
+4.93%
|
3,272.80
|
| Payables And Accrued Expenses |
|
2,973.60
-12.65%
|
3,404.40
+15.43%
|
2,949.20
+38.44%
|
2,130.30
|
| Payables |
|
546.80
-43.77%
|
972.50
+47.19%
|
660.70
-12.07%
|
751.40
|
| Accounts Payable |
|
432.00
+1.84%
|
424.20
+5.18%
|
403.30
-17.95%
|
491.50
|
| Current Accrued Expenses |
|
2,426.80
-0.21%
|
2,431.90
+6.27%
|
2,288.50
+65.97%
|
1,378.90
|
| Pensionand Other Post Retirement Benefit Plans Current |
|
375.80
+0.00%
|
375.80
+12.15%
|
335.10
-15.29%
|
395.60
|
| Total Tax Payable |
|
114.80
-79.06%
|
548.30
+113.01%
|
257.40
-0.96%
|
259.90
|
| Current Debt And Capital Lease Obligation |
|
—
|
1,748.60
+1065.73%
|
150.00
|
—
|
| Current Debt |
|
—
|
1,748.60
+1065.73%
|
150.00
|
—
|
| Other Current Borrowings |
|
—
|
1,748.60
+1065.73%
|
150.00
|
—
|
| Other Current Liabilities |
|
—
|
—
|
838.40
+12.25%
|
746.90
|
| Total Non Current Liabilities Net Minority Interest |
|
7,833.30
+34.95%
|
5,804.50
-32.59%
|
8,611.10
+9.10%
|
7,892.90
|
| Long Term Debt And Capital Lease Obligation |
|
6,577.20
+34.73%
|
4,881.70
-32.09%
|
7,188.20
+8.68%
|
6,614.00
|
| Long Term Debt |
|
6,286.80
+38.26%
|
4,547.20
-33.01%
|
6,788.20
+8.08%
|
6,281.00
|
| Long Term Capital Lease Obligation |
|
290.40
-13.18%
|
334.50
-16.38%
|
400.00
+20.12%
|
333.00
|
| Non Current Deferred Liabilities |
|
507.60
+166.46%
|
190.50
-70.32%
|
641.80
+91.75%
|
334.70
|
| Non Current Deferred Taxes Liabilities |
|
507.60
+166.46%
|
190.50
-70.32%
|
641.80
+91.75%
|
334.70
|
| Other Non Current Liabilities |
|
748.50
+2.21%
|
732.30
-6.25%
|
781.10
-17.27%
|
944.20
|
| Stockholders Equity |
|
18,256.80
+9.22%
|
16,716.00
+12.95%
|
14,799.40
+10.46%
|
13,397.90
|
| Common Stock Equity |
|
18,256.80
+9.22%
|
16,716.00
+12.95%
|
14,799.40
+10.46%
|
13,397.90
|
| Capital Stock |
|
0.10
+0.00%
|
0.10
+0.00%
|
0.10
+0.00%
|
0.10
|
| Common Stock |
|
0.10
+0.00%
|
0.10
+0.00%
|
0.10
+0.00%
|
0.10
|
| Preferred Stock |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Share Issued |
|
170.60
+0.64%
|
169.52
+0.49%
|
168.70
+0.54%
|
167.80
|
| Ordinary Shares Number |
|
146.80
+0.74%
|
145.72
+0.57%
|
144.90
+0.63%
|
144.00
|
| Treasury Shares Number |
|
23.80
+0.00%
|
23.80
+0.00%
|
23.80
+0.00%
|
23.80
|
| Additional Paid In Capital |
|
863.10
+51.58%
|
569.40
+88.23%
|
302.50
+312.69%
|
73.30
|
| Retained Earnings |
|
20,552.70
+6.71%
|
19,259.80
+9.26%
|
17,627.60
+7.05%
|
16,466.50
|
| Gains Losses Not Affecting Retained Earnings |
|
-182.00
-33.63%
|
-136.20
+11.39%
|
-153.70
+6.79%
|
-164.90
|
| Treasury Stock |
|
2,977.10
+0.00%
|
2,977.10
+0.00%
|
2,977.10
+0.00%
|
2,977.10
|
| Minority Interest |
|
—
|
—
|
0.00
+100.00%
|
-9.50
|
| Other Equity Adjustments |
|
-182.00
-33.63%
|
-136.20
+11.39%
|
-153.70
+6.79%
|
-164.90
|
| Total Equity Gross Minority Interest |
|
18,256.80
+9.22%
|
16,716.00
+12.95%
|
14,799.40
+10.54%
|
13,388.40
|
| Total Capitalization |
|
24,543.60
+15.43%
|
21,263.20
-1.50%
|
21,587.60
+9.70%
|
19,678.90
|
| Working Capital |
|
5,624.70
+191.74%
|
1,928.00
-43.71%
|
3,425.00
-47.46%
|
6,518.40
|
| Invested Capital |
|
24,543.60
+6.66%
|
23,011.80
+5.86%
|
21,737.60
+10.46%
|
19,678.90
|
| Total Debt |
|
6,577.20
-0.80%
|
6,630.30
-9.65%
|
7,338.20
+10.95%
|
6,614.00
|
| Net Debt |
|
3,278.30
-16.39%
|
3,920.80
-33.41%
|
5,888.30
+105.76%
|
2,861.70
|
| Capital Lease Obligations |
|
290.40
-13.18%
|
334.50
-16.38%
|
400.00
+20.12%
|
333.00
|
| Net Tangible Assets |
|
2,587.20
+373.93%
|
545.90
+151.34%
|
217.20
-96.25%
|
5,798.80
|
| Tangible Book Value |
|
2,587.20
+373.93%
|
545.90
+151.34%
|
217.20
-96.25%
|
5,798.80
|
| Available For Sale Securities |
|
431.90
|
—
|
—
|
705.70
|
| Inventories Adjustments Allowances |
|
—
|
—
|
—
|
-21.10
|
| Investmentin Financial Assets |
|
431.90
|
0.00
|
0.00
-100.00%
|
705.70
|
| Other Inventories |
|
—
|
—
|
—
|
-21.10
|
| Preferred Shares Number |
|
0.01
+0.00%
|
0.01
+0.00%
|
0.01
+0.00%
|
0.01
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
2,204.60
-23.33%
|
2,875.50
+85.85%
|
1,547.20
+11.77%
|
1,384.30
|
| Cash Flow From Continuing Operating Activities |
|
2,204.60
-23.33%
|
2,875.50
+85.85%
|
1,547.20
+11.77%
|
1,384.30
|
| Net Income From Continuing Operations |
|
1,292.90
-20.79%
|
1,632.20
+40.53%
|
1,161.50
-60.78%
|
2,961.60
|
| Depreciation Amortization Depletion |
|
779.90
+15.85%
|
673.20
+36.05%
|
494.80
-4.55%
|
518.40
|
| Depreciation |
|
272.80
-4.85%
|
286.70
+12.79%
|
254.20
-6.68%
|
272.40
|
| Amortization Cash Flow |
|
507.10
+31.20%
|
386.50
+60.64%
|
240.60
-2.31%
|
246.30
|
| Depreciation And Amortization |
|
779.90
+15.85%
|
673.20
+36.05%
|
494.80
-4.55%
|
518.40
|
| Amortization Of Intangibles |
|
507.10
+31.20%
|
386.50
+60.64%
|
240.60
-2.31%
|
246.30
|
| Other Non Cash Items |
|
456.90
-12.00%
|
519.20
+70.73%
|
304.10
-9.31%
|
335.30
|
| Stock Based Compensation |
|
290.80
-0.14%
|
291.20
+10.22%
|
264.20
+3.97%
|
254.10
|
| Provisionand Write Offof Assets |
|
—
|
—
|
—
|
—
|
| Asset Impairment Charge |
|
60.80
+1.00%
|
60.20
|
0.00
-100.00%
|
119.60
|
| Deferred Tax |
|
361.60
+328.72%
|
-158.10
+48.30%
|
-305.80
-81.38%
|
-168.60
|
| Deferred Income Tax |
|
361.60
+328.72%
|
-158.10
+48.30%
|
-305.80
-81.38%
|
-168.60
|
| Operating Gains Losses |
|
19.30
+50.78%
|
12.80
-95.38%
|
277.10
+115.87%
|
-1,745.80
|
| Gain Loss On Investment Securities |
|
19.30
-80.97%
|
101.40
-63.41%
|
277.10
+4.21%
|
265.90
|
| Gain Loss On Sale Of PPE |
|
0.00
+100.00%
|
-88.60
|
0.00
+100.00%
|
-503.70
|
| Change In Working Capital |
|
-1,057.60
-581.44%
|
-155.20
+76.08%
|
-648.70
+27.14%
|
-890.30
|
| Change In Receivables |
|
42.10
-78.32%
|
194.20
+242.50%
|
56.70
+125.49%
|
-222.40
|
| Changes In Account Receivables |
|
102.70
-53.80%
|
222.30
+262.64%
|
61.30
+130.14%
|
-203.40
|
| Change In Inventory |
|
-64.70
+76.37%
|
-273.80
-109.17%
|
-130.90
+59.12%
|
-320.20
|
| Change In Payables And Accrued Expense |
|
171.10
+595.53%
|
24.60
+112.20%
|
-201.60
-77.78%
|
-113.40
|
| Change In Accrued Expense |
|
171.10
+595.53%
|
24.60
+112.20%
|
-201.60
-77.78%
|
-113.40
|
| Change In Other Working Capital |
|
-1,206.10
-1103.69%
|
-100.20
+73.13%
|
-372.90
-59.15%
|
-234.30
|
| Investing Cash Flow |
|
-1,371.10
-71.56%
|
-799.20
+80.51%
|
-4,101.00
-360.12%
|
1,576.60
|
| Cash Flow From Continuing Investing Activities |
|
-1,371.10
-71.56%
|
-799.20
+80.51%
|
-4,101.00
-360.12%
|
1,576.60
|
| Net PPE Purchase And Sale |
|
-153.80
-0.07%
|
-153.70
+44.51%
|
-277.00
-180.92%
|
342.30
|
| Purchase Of PPE |
|
-153.80
-0.07%
|
-153.70
+44.51%
|
-277.00
-15.27%
|
-240.30
|
| Sale Of PPE |
|
—
|
0.00
|
0.00
-100.00%
|
582.60
|
| Capital Expenditure |
|
-235.40
+34.57%
|
-359.80
-15.54%
|
-311.40
-28.04%
|
-243.20
|
| Net Investment Purchase And Sale |
|
-1,178.60
-914.51%
|
144.70
-93.87%
|
2,359.70
+960.54%
|
222.50
|
| Purchase Of Investment |
|
-1,258.30
|
0.00
+100.00%
|
-5,140.70
-49.07%
|
-3,448.50
|
| Sale Of Investment |
|
79.70
-44.92%
|
144.70
-98.07%
|
7,500.40
+104.31%
|
3,671.00
|
| Net Business Purchase And Sale |
|
0.00
+100.00%
|
-668.00
+89.12%
|
-6,138.00
-719.81%
|
990.30
|
| Purchase Of Business |
|
0.00
+100.00%
|
-1,074.80
+84.48%
|
-6,926.10
|
0.00
|
| Gain Loss On Sale Of Business |
|
—
|
0.00
|
0.00
+100.00%
|
-1,505.40
|
| Net Intangibles Purchase And Sale |
|
-81.60
+30.55%
|
-117.50
-241.57%
|
-34.40
-1086.21%
|
-2.90
|
| Purchase Of Intangibles |
|
-81.60
+60.41%
|
-206.10
-499.13%
|
-34.40
-1086.21%
|
-2.90
|
| Net Other Investing Changes |
|
42.90
+1012.77%
|
-4.70
+58.41%
|
-11.30
-146.31%
|
24.40
|
| Financing Cash Flow |
|
-301.90
+55.83%
|
-683.50
-557.80%
|
149.30
+108.54%
|
-1,747.30
|
| Cash Flow From Continuing Financing Activities |
|
-301.90
+55.83%
|
-683.50
-557.80%
|
149.30
+108.54%
|
-1,747.30
|
| Net Issuance Payments Of Debt |
|
-16.90
+97.40%
|
-650.00
-447.04%
|
187.30
+118.69%
|
-1,002.20
|
| Issuance Of Debt |
|
1,733.10
|
0.00
-100.00%
|
997.20
|
0.00
|
| Repayment Of Debt |
|
-1,750.00
-169.23%
|
-650.00
+19.74%
|
-809.90
+19.19%
|
-1,002.20
|
| Long Term Debt Issuance |
|
1,733.10
|
0.00
-100.00%
|
997.20
|
0.00
|
| Long Term Debt Payments |
|
-1,750.00
-169.23%
|
-650.00
+19.74%
|
-809.90
+19.19%
|
-1,002.20
|
| Net Long Term Debt Issuance |
|
-16.90
+97.40%
|
-650.00
-447.04%
|
187.30
+118.69%
|
-1,002.20
|
| Net Common Stock Issuance |
|
—
|
0.00
|
0.00
+100.00%
|
-750.00
|
| Common Stock Payments |
|
—
|
0.00
|
0.00
+100.00%
|
-750.00
|
| Repurchase Of Capital Stock |
|
—
|
0.00
|
0.00
+100.00%
|
-750.00
|
| Proceeds From Stock Option Exercised |
|
-10.00
+68.05%
|
-31.30
+29.35%
|
-44.30
-2231.58%
|
-1.90
|
| Net Other Financing Charges |
|
-275.00
-12400.00%
|
-2.20
-134.92%
|
6.30
-7.35%
|
6.80
|
| Changes In Cash |
|
531.60
-61.83%
|
1,392.80
+157.92%
|
-2,404.50
-298.13%
|
1,213.60
|
| Effect Of Exchange Rate Changes |
|
101.90
+250.52%
|
-67.70
-292.88%
|
35.10
+163.02%
|
-55.70
|
| Beginning Cash Position |
|
2,375.00
+126.21%
|
1,049.90
-69.29%
|
3,419.30
+51.20%
|
2,261.40
|
| End Cash Position |
|
3,008.50
+26.67%
|
2,375.00
+126.21%
|
1,049.90
-69.29%
|
3,419.30
|
| Free Cash Flow |
|
1,969.20
-21.72%
|
2,515.70
+103.57%
|
1,235.80
+8.30%
|
1,141.10
|
| Interest Paid Supplemental Data |
|
264.10
+7.62%
|
245.40
-2.70%
|
252.20
-3.92%
|
262.50
|
| Income Tax Paid Supplemental Data |
|
864.00
+143.31%
|
355.10
-52.06%
|
740.70
+182.17%
|
262.50
|
| Earnings Losses From Equity Investments |
|
—
|
0.00
|
0.00
+100.00%
|
-2.60
|
| Sale Of Business |
|
0.00
-100.00%
|
406.80
-48.38%
|
788.10
-20.42%
|
990.30
|
| Sale Of Intangibles |
|
0.00
-100.00%
|
88.60
|
0.00
|
0.00
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
- 8-K2026-04-06 View
- 42026-04-03 View
- 8-K2026-03-31 View
- 8-K2026-03-11 View
- 42026-02-17 View
- 42026-02-17 View
- 42026-02-17 View
- 42026-02-17 View
- 42026-02-17 View
- 42026-02-17 View
- 42026-02-17 View
- 42026-02-17 View
- 42026-02-17 View
- 42026-02-17 View
- 8-K2026-02-11 View
- 42026-02-10 View
- 42026-02-10 View
- 42026-02-10 View
- 42026-02-10 View
- 42026-02-10 View
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|